After a court issued a ruling last spring that a Yemeni detainee held in U.S. custody should be released, the opinion was briefly published in the case docket and then abruptly withdrawn for classification review. When it reappeared, reporter Dafna Linzer discovered, it was not only redacted but had been significantly altered.
“The alterations are extensive,” she found. “Sentences were rewritten. Footnotes that described disputes and discrepancies in the government’s case were deleted. Even the date and circumstances of [the detainee’s] arrest were changed.”
Yet in what seems like an insult to the integrity of the judicial process, no indication was given that the original opinion had been modified — not just censored — as a consequence of the classification review. ProPublica obtained both versions of the ruling and published a comparison of them, highlighting the missing or altered passages. See “In Gitmo Opinion, Two Versions of Reality” by Dafna Linzer, ProPublica (co-published with The National Law Journal), October 8.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.